The importance of balanced pro-inflammatory and anti-inflammatory mechanisms in diffuse lung disease

[1]  M. Burdick,et al.  IL-12 attenuates bleomycin-induced pulmonary fibrosis. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[2]  J. Hohlfeld,et al.  Pulmonary surfactant in birds: coping with surface tension in a tubular lung. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[3]  D. Anthony,et al.  Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. , 2001, The Journal of clinical investigation.

[4]  Klemens Budde,et al.  CC chemokine receptor 5 and renal-transplant survival , 2001, The Lancet.

[5]  P. Sly,et al.  Altered stability of pulmonary surfactant in SP-C-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  G. Hoyle,et al.  IL-9 and lung fibrosis: a Th2 good guy? , 2001, American journal of respiratory cell and molecular biology.

[7]  J. Renauld,et al.  Interleukin-9 reduces lung fibrosis and type 2 immune polarization induced by silica particles in a murine model. , 2001, American journal of respiratory cell and molecular biology.

[8]  H. Lei,et al.  Allergen‐induced bronchial inflammation is associated with decreased levels of surfactant proteins A and D in a murine model of asthma , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[9]  M. Rothenberg,et al.  Interleukin-5-mediated Allergic Airway Inflammation Inhibits the Human Surfactant Protein C Promoter in Transgenic Mice* , 2001, The Journal of Biological Chemistry.

[10]  H. Haller,et al.  Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. , 2000, Journal of cell science.

[11]  Y. Fukushima,et al.  Increased levels of surfactant protein A and D in bronchoalveolar lavage fluids in patients with bronchial asthma. , 2000, The European respiratory journal.

[12]  S T Holgate,et al.  Altered airway surfactant phospholipid composition and reduced lung function in asthma. , 2000, Journal of applied physiology.

[13]  S. Tibby,et al.  Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. , 2000, American journal of respiratory and critical care medicine.

[14]  K. Welsh,et al.  Correspondence and requests for reprints should be addressed to Dr. Martin , 2022 .

[15]  Chen,et al.  Suppression of neural activity of bronchial irritant receptors by surface‐active phospholipid in comparison with topical drugs commonly prescribed for asthma , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  U. Holmskov,et al.  Localization of Lung Surfactant Protein D on Mucosal Surfaces in Human Tissues1 , 2000, The Journal of Immunology.

[17]  M Ikegami,et al.  Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Y. Kaneda,et al.  Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[19]  G. Davis,et al.  Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. , 2000, Gastroenterology.

[20]  M. Loda,et al.  Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1 , 2000, Nature.

[21]  M. Prystowsky,et al.  Divergent regulation of the murine CC chemokine C10 by Th(1) and Th(2) cytokines. , 2000, Cytokine.

[22]  L. Lichtenstein,et al.  Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. , 2000, The Journal of pharmacology and experimental therapeutics.

[23]  T. Kupper,et al.  Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. , 2000, The Journal of investigative dermatology.

[24]  N. Krug,et al.  Surfactant function affected by airway inflammation and cooling: possible impact on exercise-induced asthma. , 2000, The European respiratory journal.

[25]  N. Krug,et al.  Phospholipid molecular species of bronchoalveolar lavage fluid after local allergen challenge in asthma. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[26]  M. Burdick,et al.  IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. , 1999, Journal of immunology.

[27]  S. Romagnani.  Th1/Th2 cells. , 1999, Inflammatory bowel diseases.

[28]  V. Petkov,et al.  A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis. , 1999, The New England journal of medicine.

[29]  D. Postma,et al.  Interferon-gamma and interleukin-4 differentially regulate ICAM-1 and VCAM-1 expression on human lung fibroblasts. , 1999, The European respiratory journal.

[30]  D. Purdie,et al.  Interleukin‐10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa , 1999, Hepatology.

[31]  S. Nagata,et al.  Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. , 1999, The Journal of clinical investigation.

[32]  G. Köhler,et al.  Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling. , 1999, Journal of immunology.

[33]  M. Burdick,et al.  Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. , 1999, Journal of immunology.

[34]  J. Renauld,et al.  Lung fibrosis induced by silica particles in NMRI mice is associated with an upregulation of the p40 subunit of interleukin-12 and Th-2 manifestations. , 1999, American journal of respiratory cell and molecular biology.

[35]  R. Homer,et al.  Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. , 1999, The Journal of clinical investigation.

[36]  E. Amento,et al.  Transcriptional inhibition of stromelysin by interferon‐γ in normal human fibroblasts is mediated by the AP‐1 domain , 1999, Journal of cellular biochemistry.

[37]  J. Whitsett,et al.  Surfactant protein A (SP-A) gene targeted mice. , 1998, Biochimica et biophysica acta.

[38]  E. Crouch,et al.  Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production. , 1998, Journal of immunology.

[39]  M. Burdick,et al.  Interleukin-10 regulates quartz-induced pulmonary inflammation in rats. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[40]  F. Graham,et al.  Transfer of tumor necrosis factor-alpha to rat lung induces severe pulmonary inflammation and patchy interstitial fibrogenesis with induction of transforming growth factor-beta1 and myofibroblasts. , 1998, The American journal of pathology.

[41]  C. Daniels,et al.  EVOLUTION OF SURFACE ACTIVITY RELATED FUNCTIONS OF VERTEBRATE PULMONARY SURFACTANT , 1998, Clinical and experimental pharmacology & physiology.

[42]  C. Dinarello.  Interleukin‐1β, Interleukin‐18, and the Interleukin‐1β Converting Enzyme a , 1998 .

[43]  T. Fukuda,et al.  Suppressive Effects of SP-A on Ionomycin-Induced IL-8 Production and Release by Eosinophils , 1998, International Archives of Allergy and Immunology.

[44]  A. Anzueto,et al.  Effects of Aerosolized Surfactant in Patients With Stable Chronic Bronchitis: A Prospective Randomized Controlled Trial , 1997 .

[45]  D. Sims,et al.  Heterogeneity of the composition and thickness of tracheal mucus in rats. , 1997, The American journal of physiology.

[46]  J. Whitsett,et al.  Interleukin-4 alters epithelial cell differentiation and surfactant homeostasis in the postnatal mouse lung. , 1997, American journal of respiratory cell and molecular biology.

[47]  S. Kunkel,et al.  Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-gamma and IL-4 knockout mice: analysis of local and regional cytokine and chemokine networks. , 1997, Journal of immunology.

[48]  J. Widdicombe.  Airway liquid: a barrier to drug diffusion? , 1997, The European respiratory journal.

[49]  J. Hohlfeld,et al.  Aerosolized surfactant inhibits acetylcholine-induced airway obstruction in rats. , 1997, European Respiratory Journal.

[50]  R. Whyte,et al.  The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. , 1997, Journal of immunology.

[51]  R. Welliver,et al.  Surfactant Dysfunction Develops in BALB/c Mice Infected with Respiratory Syncytial Virus , 1997, Pediatric Research.

[52]  C. Poets,et al.  Conductive airway surfactant: surface-tension function, biochemical composition, and possible alveolar origin. , 1997, American journal of respiratory cell and molecular biology.

[53]  M. Fujimura,et al.  Surface activity of sputum from acute asthmatic patients. , 1997, American journal of respiratory and critical care medicine.

[54]  M. Fujimura,et al.  Effect of surfactant inhalation on allergic bronchoconstriction in guinea pigs , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[55]  H. Hamm,et al.  The role of pulmonary surfactant in obstructive airways disease. , 1997, The European respiratory journal.

[56]  U. Kishore,et al.  Interaction of human lung surfactant proteins A and D with mite (Dermatophagoides pteronyssinus) allergens , 1996, Clinical and experimental immunology.

[57]  B. Hills.  Asthma: is there an airway receptor barrier? , 1996, Thorax.

[58]  B. Stripp,et al.  Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[59]  R. Veldhuizen,et al.  Surfactant associated protein-A inhibits human lymphocyte proliferation and IL-2 production. , 1996, American journal of respiratory cell and molecular biology.

[60]  B. Beutler,et al.  The tumor necrosis factor ligand and receptor families. , 1996, The New England journal of medicine.

[61]  T. W. van der Mark,et al.  Surfactant nebulization does not alter airflow obstruction and bronchial responsiveness to histamine in asthmatic children. , 1996, American journal of respiratory and critical care medicine.

[62]  L. Wang,et al.  Pulmonary surfactant given prophylactically alleviates an asthma attack in guinea‐pigs , 1996, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[63]  T. Miyata,et al.  Activated eosinophils stimulate phosphatidylcholine secretion in primary culture of rat type II pneumocytes. , 1996, Biochemistry and molecular biology international.

[64]  L. Wang,et al.  Surfactant dysfunction develops when the immunized guinea‐pig is challenged with ovalbumin aerosol , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[65]  D. Lamb,et al.  A type 2 (Th2‐like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA) , 1995, Clinical and experimental immunology.

[66]  T. Standiford,et al.  Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. , 1995, Journal of immunology.

[67]  B. Stripp,et al.  Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[68]  T. Standiford,et al.  Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. , 1995, Journal of immunology.

[69]  F. Martinez,et al.  Increased interleukin-1 receptor antagonist in idiopathic pulmonary fibrosis. A compartmental analysis. , 1995, American journal of respiratory and critical care medicine.

[70]  G. Laurent,et al.  Interleukin-8. Differential expression in lone fibrosing alveolitis and systemic sclerosis. , 1995, American journal of respiratory and critical care medicine.

[71]  L. Duffy,et al.  Pulmonary surfactant maintains patency of conducting airways in the rat. , 1995, American journal of respiratory and critical care medicine.

[72]  S. Kremlev,et al.  Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro. , 1994, The American journal of physiology.

[73]  M. King,et al.  Exogenous surfactant enhances mucociliary clearance in the anaesthetized dog. , 1994, The European respiratory journal.

[74]  J. Whitsett,et al.  Temporal-spatial distribution of SP-B and SP-C proteins and mRNAs in developing respiratory epithelium of human lung. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[75]  C. Vesin,et al.  Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. , 1994, The European respiratory journal.

[76]  M. Peão,et al.  Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin , 1994, The Anatomical record.

[77]  Marianne Geiser,et al.  Surfactant and inhaled particles in the conducting airways: Structural, stereological, and biophysical aspects , 1993, Microscopy research and technique.

[78]  T. Standiford,et al.  Interleukin-1 receptor antagonist expression in sarcoidosis. , 1993, The American review of respiratory disease.

[79]  J. Whitsett,et al.  Developmental expression of SP-A and SP-A mRNA in the proximal and distal respiratory epithelium in the human fetus and newborn. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[80]  R. Whyte,et al.  Macrophage inflammatory protein-1 alpha expression in interstitial lung disease. , 1993, Journal of immunology.

[81]  W. Seeger,et al.  Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. , 1993, The European respiratory journal.

[82]  G. Enhorning,et al.  Disruption of pulmonary surfactant's ability to maintain openness of a narrow tube. , 1993, Journal of applied physiology.

[83]  H. Colten,et al.  Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. , 1993, The New England journal of medicine.

[84]  A. Brody,et al.  Recombinant interferon-gamma reduces PDGF-induced lung fibroblast growth but stimulates PDGF production by alveolar macrophages in vitro. , 1993, Chest.

[85]  H. Katai,et al.  Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. , 1992, The Journal of clinical investigation.

[86]  H. Geuze,et al.  Immunocytochemical localization of surfactant protein D (SP-D) in type II cells, Clara cells, and alveolar macrophages of rat lung. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[87]  R. Lutter,et al.  Surfactant protein A in bronchoalveolar lavage fluid. , 1992, The Journal of laboratory and clinical medicine.

[88]  T. Standiford,et al.  Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8. , 1992, The American review of respiratory disease.

[89]  O. Braun-falco,et al.  Treatment of systemic sclerosis with γ‐interferon , 1992 .

[90]  G. Enhorning,et al.  Pulmonary surfactant will secure free airflow through a narrow tube. , 1991, Journal of applied physiology.

[91]  F. Kelly,et al.  Developmental variation in whole human lung phosphatidylcholine molecular species: a comparison with guinea pig and rat. , 1991, Early human development.

[92]  H. Sasaki,et al.  Effect of artificial surfactant on ciliary beat frequency in guinea pig trachea. , 1991, Respiration physiology.

[93]  M. Fujimura,et al.  A pilot study of surfactant inhalation in the treatment of asthmatic attack. , 1991, Arerugi = [Allergy].

[94]  P. Vassalli,et al.  Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis , 1989, The Journal of experimental medicine.

[95]  B. Berman,et al.  Differential regulation of collagen, glycosaminoglycan, fibronectin, and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-alpha and beta and tumor necrosis factor-alpha and beta. , 1989, The Journal of investigative dermatology.

[96]  G. Enhorning,et al.  Artificial pulmonary surfactant inhibited by proteins. , 1987, Journal of applied physiology.

[97]  D. Hyde,et al.  Ameliorating effect of murine interferon gamma on bleomycin-induced lung collagen fibrosis in mice. , 1986, Biochemical medicine and metabolic biology.

[98]  G. Enhörning,et al.  Pulmonary surfactant release in fetal rabbits as affected by terbutaline and aminophyllin. , 1981, Scandinavian journal of clinical and laboratory investigation.

[99]  B. Benson,et al.  Immunosuppressive activity of canine pulmonary surface active material. , 1979, Journal of immunology.

[100]  R. Mason,et al.  Pulmonary alveolar type II cells isolated from rats. Release of phosphatidylcholine in response to beta-adrenergic stimulation. , 1979, The Journal of clinical investigation.

[101]  M. Turner-Warwick,et al.  Precapillary Systemic-pulmonary Anastomoses , 1963, Thorax.

[102]  M. Avery,et al.  Surface properties in relation to atelectasis and hyaline membrane disease. , 1959, A.M.A. journal of diseases of children.

[103]  C. Dinarello.  Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. , 1998, Annals of the New York Academy of Sciences.

[104]  J. Renauld,et al.  Role of interleukin-10 in the lung response to silica in mice. , 1998, American journal of respiratory cell and molecular biology.

[105]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[106]  M. Burdick,et al.  Interleukin-10 regulates quartz-induced pulmonary inflammation in rats. , 1998, American Journal of Physiology.

[107]  S. Hashimoto,et al.  Morphometric analysis of the immunohistochemical expression of Clara cell 10-kDa protein and surfactant apoproteins A and B in the developing bronchi and bronchioles of human fetuses and neonates , 1998, Virchows Archiv.

[108]  H. Lei,et al.  Inhibitory effect of pulmonary surfactant proteins A and D on allergen-induced lymphocyte proliferation and histamine release in children with asthma. , 1998, American journal of respiratory and critical care medicine.

[109]  A. Jobe,et al.  Decreased lung compliance and air trapping in heterozygous SP-B-deficient mice. , 1997, American journal of respiratory cell and molecular biology.

[110]  W. Seeger,et al.  Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. , 1996, American journal of respiratory and critical care medicine.

[111]  G. Enhorning.  Pulmonary surfactant function in alveoli and conducting airways , 1996 .

[112]  黒木 茂高.  Determination of various cytokines and type III procollagen aminopeptide levels in bronchoalveolar lavage fluid of the patients with pulmonary fibrosis : inverse correlation between type III procollagen aminopeptide and interferon-γ in progressive patients , 1995 .

[113]  A. Ohta,et al.  Determination of various cytokines and type III procollagen aminopeptide levels in bronchoalveolar lavage fluid of the patients with pulmonary fibrosis: inverse correlation between type III procollagen aminopeptide and interferon-gamma in progressive patients. , 1995, British journal of rheumatology.

[114]  R. Thompson,et al.  Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica. , 1993, Cytokine.

[115]  O. Braun-falco,et al.  Treatment of systemic sclerosis with gamma-interferon. , 1992, The British journal of dermatology.

[116]  R. Barrow.  Chemical structure of phospholipids in the lungs and airways of sheep. , 1990, Respiration physiology.

[117]  L. V. Golde.  Synthesis of Surfactant Lipids in the Adult Lung , 1985 .

[118]  R. G. Sitrin,et al.  The effect of pulmonary surface-active material on the generation and expression of murine B- and T-lymphocyte effector functions in vitro. , 1985, Experimental lung research.